Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Other Non-Current Liabilities came in at $551.0 million in Q2 2026, down 13.64% year-over-year from $638.0 million in Q2 2025, and up 17.99% quarter-over-quarter from $467.0 million in Q1 2026.
Analysis
Elanco Animal Health (ELAN) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Other Non-Current Liabilities across 10 years of filings, most recently posting $551.0 million for Q2 2026.
- In Q2 2026, Other Non-Current Liabilities fell 13.64% year-over-year to $551.0 million; the TTM figure through Jun 2026 stood at $551.0 million (down 13.64% YoY), while the FY2025 annual figure was $585.0 million, up 93.71% from the prior year.
- Other Non-Current Liabilities came in at $551.0 million for Q2 2026 at Elanco Animal Health, up from $467.0 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $638.0 million in Q2 2025 to a low of $225.0 million in Q3 2022.
- Average Other Non-Current Liabilities over 5 years is $422.2 million, with a median of $448.5 million recorded in 2023.
- Year-over-year, Other Non-Current Liabilities fell 26.52% in 2024 and jumped 93.71% in 2025.
- Over 5 years, Other Non-Current Liabilities stood at $229.0 million in 2022, then soared by 79.48% to $411.0 million in 2023, then slipped by 26.52% to $302.0 million in 2024, then jumped by 93.71% to $585.0 million in 2025, then decreased by 5.81% to $551.0 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $551.0 million in Q2 2026, $467.0 million in Q1 2026, and $585.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.52 Bn | 40.33 Bn | 779.09 Mn |
| 2 | Zoetis | 30.69 Bn | 29.02 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 551.00 Mn |
| Mar 31, 2026 | 467.00 Mn |
| Dec 31, 2025 | 585.00 Mn |
| Sep 30, 2025 | 607.00 Mn |
| Jun 30, 2025 | 638.00 Mn |
| Mar 31, 2025 | 487.00 Mn |
| Dec 31, 2024 | 302.00 Mn |
| Sep 30, 2024 | 587.00 Mn |
| Jun 30, 2024 | 465.00 Mn |
| Mar 31, 2024 | 474.00 Mn |
| Dec 31, 2023 | 411.00 Mn |
| Sep 30, 2023 | 432.00 Mn |
| Jun 30, 2023 | 411.00 Mn |
| Mar 31, 2023 | 245.00 Mn |
| Dec 31, 2022 | 229.00 Mn |
| Sep 30, 2022 | 225.00 Mn |
| Jun 30, 2022 | 242.00 Mn |
| Mar 31, 2022 | 242.00 Mn |
| Dec 31, 2021 | 262.00 Mn |
| Sep 30, 2021 | 220.00 Mn |